# iRestore Forensic Signal Analysis: Ancestral Cranial Photonics Node or Hair-Growth Lamp? --- ## 1. Executive Synthesis The public record does not support reading iRestore as a covert neurotechnology program, a digital twinning platform, a consciousness-capture architecture, or a continuity-adjacent system. None of those categories appear anywhere in Freedom Laser Therapy's patents, filings, or public language. What the record does support — when all signal layers are overlaid — is a more modest but still analytically significant conclusion: **iRestore is a biologically interesting cranial photonic product operating at the edge of two scientifically distinct regimes (cosmetic scalp stimulation and transcranial photobiomodulation), embedded in a discursive habitat and corporate genealogy that are not fully explained by ordinary hair-loss marketing logic, and whose app-based telemetry and daily-use habituation architecture are structurally pre-adapted for digital phenotyping upgrades that could, in principle, evolve toward a consumer cranial neurotechnology stack.** The strongest individual signals are: (1) a corporate genealogy explicitly rooted in laser-mediated neurochemical modulation (endorphin release, craving suppression, reward pathway intervention), not merely topical therapy; (2) advertisement placement on shows whose entire intellectual content is organized around consciousness-edge speculation, simulation theory, UFO ontology, and post-biological futures — an unusually distant context for a hair-growth brand's direct-response advertising; (3) a MAUDE/TPLC adverse-event profile that includes headaches (3 events), inner ear pain, sleeplessness due to headaches, and cysts — symptoms more consistent with local thermal/photonic off-target effects than with pure scalp follicle interaction, and overlap with documented tPBM adverse-event signatures; (4) a regulatory classification anomaly (cleared as an "Infrared lamp" under 21 CFR 890.5500, which technically defines infrared as ≥700nm, while the device operates at 625–680nm); (5) an adjacent patent ecosystem that is rapidly building the exact technology stack that would transform a consumer cranial light helmet into a closed-loop adaptive neural modulation system with digital phenotyping capabilities; and (6) an app telemetry layer that, while currently modest (session logs, photos, reminders, user content, identifiers), already possesses the data-collection grammar of a longitudinal behavioral monitoring platform. The gap between what these signals imply and what they prove is large but not infinite. The most defensible steelman is: **iRestore is currently a consumer hair-growth device with no documented brain-directed function, but it sits at an architectural and scientific threshold from which the trajectory to consumer cranial neurotechnology is short, technically coherent, and already being built by adjacent actors using the same physical substrate.** *** ## 2. Verified Facts The following claims are directly confirmed by primary sources (FDA clearance documents, MAUDE/TPLC database, App Store privacy declarations, corporate filings, patent records, peer-reviewed literature, company websites). ### Device Hardware - The iRestore Elite (product code ID-510) received FDA 510(k) clearance on October 13, 2022 (K222081), classified under 21 CFR 890.5500 (Infrared lamp), Class II, Product Code OAP.[^1] - The device contains 300 five-milliwatt diode lasers and 200 five-milliwatt super-luminescent diodes emitting at 680 ± 10 nm, 655 ± 10 nm, and 625 ± 10 nm respectively, totaling 2,500 mW per 12-minute daily treatment session.[^1] - Physical configuration is a helmet with ABS plastic shell, silicone pad fixation ring, operating on line voltage 100–240V.[^1] - Lasers are Class 3R (< 5mW each).[^2] - Prior cleared models: iRestore Professional 282 (K183417, 282 diodes, 655nm, 1,410 mW, 25-min EOD); iRestore Essential (120 diodes, 655nm, 600 mW).[^3][^4] - Physical manufacturer: Remax Medi-Tech (Shenzhen) Corporation.[^1] - Freedom Laser Therapy, Inc. headquarters: 16782 Von Karman Ave, Unit 15, Irvine, CA, 92606.[^1] ### FDA Regulatory Classification - 21 CFR 890.5500 defines "Infrared lamp" as "a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating".[^5] - iRestore's operating wavelengths (625–680nm) fall below the 700nm threshold defined by the regulation, placing the device in the visible red spectrum — not technically infrared by the regulatory definition.[^2][^5] - Clearance was obtained via 510(k) substantial equivalence to predicate device ID-500 iRestore Hair Growth System (K213094).[^1] - The stated indications for use: "promote hair growth in males who have Norwood-Hamilton Classifications of IIa-V, and in females with androgenetic alopecia who have Ludwig-Savin Classifications of I-II".[^1] - No brain, cognitive, neurological, or continuity-related indications appear anywhere in the FDA clearance documents.[^1] ### MAUDE / TPLC Adverse Events - The FDA TPLC database for product code OAP (all manufacturers) reports 8 MDRs from 2021 to 2025.[^6] - Patient problem counts: Headache (3 MDRs / 3 events); Hair Loss (3 / 3); No Clinical Signs (2 / 2); Hypersensitivity/Allergic reaction (1 / 1); Cyst(s) (1 / 1); Itching Sensation (1 / 1); Burns (1 / 1); Erythema (1 / 1); Pain (1 / 1); Hemorrhage/Bleeding (1 / 1).[^6] - One verified iRestore MAUDE report (MDR ID 12066670) describes: cysts that began bleeding on the scalp, and references user community complaints including "severe headaches, itchy scalp, unbearable pain, eye irritation, sleeplessness due to headaches, rash, scalp damage, scalp pain, inner ear pain".[^7] - The website states: "there are no negative side effects when using the low-level light therapy (LLLT)".[^7] ### Corporate Genealogy - Freedom Laser Therapy, LLC was founded April 2003 by Craig Nabat in West Hollywood, California, explicitly as a laser therapy smoking-cessation clinic.[^8][^9] - The company treated over 10,000 smokers using low-level laser therapy targeting acupuncture points.[^10] - Freedom Laser Therapy's own public description of its smoking cessation mechanism: "We harness the power of pain-free low-level laser therapy to target specific acupuncture points on your hands, face, wrists, and ears. This stimulates the release of endorphins, intending to relax you, ease anxiety, reduce cravings, and alleviate nicotine withdrawal symptoms".[^10] - The Freedom Quit Smoking Laser headset (separate wearable product, still in development as of 2025) is described as providing "a tranquil sensation throughout the user's mind and body" via 15-minute LLLT sessions targeting ear acupuncture points.[^11][^12] - Public Citizen filed a letter with the FDA naming Freedom Laser Therapy, Inc. for illegally promoting laser therapy for smoking cessation without FDA clearance.[^13] - Craig Nabat states iRestore was developed over 9 years, launching in 2013 (implying development began concurrently with the smoking cessation clinic's operation).[^8] ### App and Telemetry - The iRestore app (developer: Freedom Laser Therapy, Inc., App Store ID 6740624438) is a free lifestyle app for iOS 15.1+.[^14] - Documented features: Bluetooth syncing, session start/pause timers, session logs, before/after photo upload, personalized reminders, device manuals and FAQs.[^14] - Apple privacy label (developer-declared): "Data used to track you: Identifiers. Data linked to your identity: Contact information, User content, Identifiers, Usage data. Data not linked to your identity: Diagnostics".[^14] - No language in any iRestore app store description, privacy policy, or company materials references AI, machine learning, adaptive dosing, predictive analytics, digital twins, or biometric profiling.[^15][^14] ### Sponsorship — American Alchemy - iRestore is a confirmed active sponsor of American Alchemy with Jesse Michels, with exclusive discount codes advertised in episode descriptions and video descriptions.[^16][^17] - Jesse Michels is an investor at Thiel Capital.[^18] - American Alchemy's self-description: "highlighting the most heretical thinkers/ideas of our time".[^19] - Documented episode topics include: UFO witnesses, abduction claims, ancient pyramid scans, Area 51 whistleblowers, simulation theory, transmission theory of consciousness, psychedelics as alien organisms, AGI, qualia, quantum physics, government UAP programs, consciousness edge speculation.[^20][^21][^22][^23] ### Sponsorship — Impact Theory - iRestore is a confirmed sponsor of Tom Bilyeu's Impact Theory.[^24][^25] - Impact Theory episode content includes: AI revolution, simulation theory, life after death, neural interfaces, consciousness, AGI, future tech, geopolitics, transhumanist self-optimization.[^26][^27][^28] *** ## 3. Signal Overlays ### 3.1 Device / Hardware Overlay **What is directly evidenced:** - Full-scalp helmet delivering 2,500 mW across 500 diodes at 625/655/680nm, covering upper cranial surface for 12 minutes daily. Photons are incident on scalp overlying cortical tissue including frontal, parietal, and temporal lobes — not merely hair follicles.[^2][^1] **What is inferential but plausible:** - Some fraction of emitted photons in the 625–680nm range will penetrate scalp (absorption + scattering), traverse skull bone (5–12% transmission at peak wavelengths), and deposit measurable but low fluence at superficial cortical tissue. This is below therapeutic tPBM thresholds but nonzero.[^29][^30] - Daily habituated use (12 min/day, indefinitely) means the skull and scalp are conditioned for photonic exposure at known coordinates — the foundational pattern of any future cranial photonics upgrade. - The helmet form factor positions diodes within millimeters of skull bone — physically identical to dedicated tPBM helmet formats used by Vielight, Theralight, and clinical tPBM researchers.[^31] **What is not supported:** - Any evidence that Freedom Laser Therapy designed the hardware to deliver therapeutic doses to brain tissue. All optimization is documented as targeting follicle depth (sub-millimeter to millimeter scale).[^1] - Any evidence the company measured or evaluated cortical light delivery.[^1] *** ### 3.2 Regulatory / MAUDE Overlay **What is directly evidenced:** - Classification anomaly: "Infrared lamp" clearance for a device emitting in the visible red spectrum (625–680nm), technically below the 700nm threshold of the regulatory definition.[^5][^1] - This anomaly results from 510(k) predicate cascading — prior cleared devices in the OAP product code also operated at visible red wavelengths, and each successive clearance was granted on substantial equivalence grounds rather than independent re-evaluation of the classification category.[^1] - TPLC patient-problem counts include 3 headache events, 3 hair-loss events (paradoxically, the device's stated effect), 1 cyst event, and events consistent with both scalp tissue reaction and possible vascular/neurological off-target effects.[^6] - MAUDE narrative text specifically records "sleeplessness due to headaches" and "inner ear pain" — neither of which maps cleanly to a pure scalp follicle interaction model.[^7] **What is inferential but plausible:** - The headache + sleeplessness + inner ear pain cluster is consistent with mild cephalic vasodilation or photonic effects on superficial cranial nerves or periosteal tissue — a known but rare adverse-event profile in transcranial photonic exposure.[^32] - The classification cascade means that as devices in the OAP code have grown more powerful (from 45 mW combs to 2,500 mW helmets), the regulatory framework has not been revisited to assess whether the new power levels raise new questions about off-target cranial effects.[^33] **What is not supported:** - MAUDE adverse events cannot demonstrate causation. The n is very small. Headaches have hundreds of plausible confounders. The MAUDE signal is consistent with the ambitious hypothesis but does not distinguish it from mundane heat/pressure/photosensitivity reactions.[^6] - No MAUDE report explicitly describes a neurological adverse event with formal clinical diagnosis.[^7][^6] *** ### 3.3 Science / tPBM Overlay **What is directly evidenced:** - The dominant effective tPBM wavelengths for brain effects are 808/810nm and 1,064nm; multiple systematic reviews and RCTs document measurable increases in cerebral blood flow, cytochrome c oxidase oxidation state, alpha and beta oscillatory changes, and functional connectivity changes at these wavelengths.[^34][^35][^36][^37] - At 808nm, 808nm light penetrates approximately 40mm into brain tissue in cadaver studies.[^38] - At 660nm, intraparenchymal penetration is measurable but substantially lower: one study found 1–7% transmission through full skull at peak wavelengths above 600nm, with 660nm showing penetration limited to gray matter (not reaching white matter in Monte Carlo simulations).[^39][^30] - Yaroslavsky et al. reported penetration depths of approximately 0.79mm in white matter and 4.06mm in gray matter at 630nm.[^29] - Published tPBM adverse events from clinical trials using NIR include: headaches (most common), perception of vivid colors, irritability, strange tastes, unusual sensations, and dizziness. One repeated-session safety study found a trend (p = 0.058) for more side effects in the NIR tPBM group vs. sham.[^32][^40][^41] - One Parkinson's disease randomized controlled trial used 635nm (visible red) alongside 810nm NIR in a helmet format, reporting 70% motor response rate — though the red vs. NIR contribution cannot be isolated from this study.[^42] **What is inferential but plausible:** - iRestore's wavelengths (625–680nm) sit within the optical biological window (600–1100nm). Some cortical photon deposition occurs; fluence levels at the cortical surface are unknown but almost certainly well below established therapeutic tPBM dosing thresholds.[^43][^44] - Cytochrome c oxidase in mitochondria absorbs in both the visible red and NIR bands; the mechanism for tPBM effects operates via the same chromophore at all effective wavelengths. The question is whether sufficient fluence reaches neurons to drive measurable photochemical responses.[^45][^46] - With 2,500 mW of total optical power and full-scalp coverage, the fluence incident on the skull surface is substantially higher than many earlier tPBM studies. Even at low skull transmission rates, the absolute power reaching cortical surface may not be negligible — though this has not been quantified for iRestore specifically. **What is not supported:** - No published study has tested iRestore-specific wavelengths and power levels for transcranial effects on brain tissue or function. - The gap between 660nm and 810nm is real and biologically significant; the cortical transmission at 660nm is substantially lower than at 810nm, and the body of literature demonstrating cognitive/neural effects is almost entirely in the 810–1064nm range.[^47][^48] - It would be incorrect to directly port established 810nm or 1064nm brain-effect literature onto iRestore's visible-red wavelength profile without wavelength-specific dosimetry. *** ### 3.4 Patent / Adjacent-IP Overlay **Freedom Laser Therapy direct patent holdings:** - No patents assignable to Freedom Laser Therapy, Inc. or Craig Nabat have been identified mentioning brain function, cognition, neural modulation, digital twins, digital phenotyping, adaptive dosing, closed-loop stimulation, consciousness, or continuity. The company's patent activity (evidenced by 510(k) filings and PR language) concerns hair follicle stimulation devices only. - Freedom Laser has a separate patent-pending quit-smoking laser headset (Freedom Quit Smoking Laser) targeting ear acupuncture points, but this device is classified as an addiction/withdrawal tool, not a brain stimulation device.[^49][^11] **Adjacent ecosystem — key patents not held by Freedom Laser:** - **WO2022234544A1** (Sens AI Inc., 2022): "Method for interval closed-loop adaptive transcranial photobiomodulation" — uses EEG biometric sensors to measure brain activity and adapt pulsed light parameters to alter brain electrical activity in real-time, delivered via head-wearable device. This is the exact upgrade pathway from static cranial PBM to closed-loop neural modulation.[^50] - **WO2023161861A1** (Sens AI Inc., 2023): "Wearable device for closed-loop transcranial photobiomodulation stimulation using cognitive testing" — combines EEG sensing with tPBM and cognitive assessment to evaluate user cognitive status and adapt treatment.[^51][^52] - **US11633621B2** (Vielight, granted 2023, filed 2018): "System and method for automated personalized brain modulation with photobiomodulation" — uses AI, machine learning, and brain-computer interface (BCI) feedback looping to automate personalized brain PBM; explicitly mentions: "modulating it to achieve targeted outcomes, which can be expressed in EEG waveforms, fMRI or clinical measures... through brain-computer interface (BCI) feedback looping and continuous and deep machine-learning AI".[^53][^54][^55] - **US10987521B1** (HOPE Laser Institute, 2021): "System and methods for treating brain related conditions with photobiomodulation therapy" — clinical brain-PBM system for concussion, neurological conditions.[^56][^57] - **US20210205634A1 / US11986667B2** (Jelikalite LLC, 2021/2024): Head-wearable device for neurological condition treatment using transcranial red and NIR wavelengths — explicitly mentions "treatment of neurological conditions" and patient data analysis via mobile devices.[^58][^59] - **WO2022109365A1** (Raybalance Inc., 2022): "Systems and methods for photobiomodulation" — includes functionality for "diagnosing or assessing a disease or disorder, and monitoring responsiveness... to treatment with therapeutic light," explicitly integrating disease diagnosis and treatment monitoring into the PBM system.[^60] - **US11730917B2** (Optoceutics / DTU, 2023): Gamma stimulation (40Hz) pulsing light source with dosage adjustment — targeting Alzheimer's disease prevention.[^61] **Assessment:** The adjacent patent ecosystem as of 2025 has already built, in separate entities, every functional component needed to convert a consumer cranial light helmet into: (a) a closed-loop neural modulation device, (b) an AI-personalized brain stimulation system, (c) a wearable EEG+PBM combined neuromodulation platform, and (d) a disease-monitoring data platform. Freedom Laser Therapy holds none of these patents, but the physical form factor and daily-use behavioral pattern it has normalized (via iRestore's consumer adoption) is structurally identical to what these patents describe. *** ### 3.5 Telemetry / App / Proto-Digital-Phenotyping Overlay **What is directly evidenced:** - The iRestore app collects: contact information, user-generated content (before/after photos, session notes), identifiers, usage data, and diagnostics.[^14] - Identifiers are declared as used for cross-app tracking.[^14] - Session logs record treatment adherence longitudinally.[^14] - User-generated photo content captures progressive scalp/cranial appearance over months or years.[^14] - The app operates in the "Lifestyle" category, not "Medical" — placing it outside stricter HIPAA/medical app frameworks.[^14] **What is inferential but plausible:** - The existing app architecture — longitudinal session compliance logs, biometric (scalp photo) time-series, user notes, contact information, usage patterns, cross-app identifier linking — constitutes the minimum viable data grammar for a digital phenotyping scaffold.[^62] - Digital phenotyping, as defined in the literature, is "the momentary, ecological quantification of behavior, as measured using sensors embedded in personal technologies". iRestore's app collects behavioral compliance data (session regularity) and biological appearance data (scalp photos) at precisely the cadence and intimacy required for longitudinal phenotype modeling.[^62] - An upgrade requiring only software additions (no new hardware) could theoretically incorporate: treatment response modeling, behavioral compliance pattern analysis, and photo-based outcome prediction. The physical device already delivers the stimulus; the app already captures the longitudinal outcome. - If the device were upgraded to NIR wavelengths with EEG capability (as adjacent patents describe), the same app architecture could accommodate cognitive state logging, neural biomarker tracking, and adaptive dosing recommendations. **What is not supported:** - No evidence that iRestore/Freedom Laser has plans, partnerships, or stated intentions to build AI modeling, adaptive dosing, EEG integration, or brain-directed capabilities.[^15][^14] - The current telemetry is typical of consumer lifestyle apps and does not exceed what one would expect from any compliance-tracking wellness device.[^14] - "Product usage data" withdrawal consent option in the privacy materials suggests a conventional data use model, not a research or analytical pipeline.[^15] *** ### 3.6 Advertiser / Discursive-Habitat Overlay **What is directly evidenced:** - iRestore is a confirmed active multi-episode sponsor of American Alchemy with Jesse Michels, offering exclusive discount codes to the show's audience.[^16][^17][^63] - Jesse Michels is a Thiel Capital investor whose show describes itself as dedicated to "the most heretical thinkers/ideas of our time".[^19][^18] - Verified American Alchemy episode topics spanning the iRestore sponsorship period: UFO witness testimony ("We Captured a 12 Foot Giant in Afghanistan," "I Spent 3 Years With Tall White Aliens At Area 51"); ancient pyramid scans and anomalous archaeology; simulation theory (Rizwan Virk); consciousness transmission theory; psychedelics as alien organisms; AGI and quantum physics; government UAP disclosure.[^20][^21][^22][^23] - iRestore is also a confirmed sponsor of Impact Theory with Tom Bilyeu, whose content covers AI revolution, neural interfaces, simulation theory, life after death, and radical self-optimization.[^24][^25][^26][^27][^28][^64] - iRestore sponsor code for American Alchemy carries the tagline: "Unlock your best hair & skin with @iRestorelaser" — notably adding "skin" to the pitch, expanding beyond hair.[^17] **What is inferential but plausible:** - A company optimizing purely for androgenetic alopecia conversion would advertise on personal finance podcasts, men's health and fitness shows, dermatology-adjacent media, and men's lifestyle channels with high-income 30–55 male demographics. American Alchemy and Impact Theory serve those demographics incidentally, but their primary intellectual identity is organized around anomalous science, non-materialist cosmology, consciousness research, and post-biological human futures — content with no obvious conversion advantage for a hair-loss device. - This suggests either: (a) iRestore's marketing team is using broad direct-response reach-buying without semantic targeting; or (b) there is a deliberate or subconscious identification between the brand's identity and the intellectual milieu of these shows — an implicit positioning in the "human optimization / technology-enhanced biology" discourse space rather than the "cosmetic defect correction" space. - The Thiel Capital connection of the show's host (Jesse Michels) is relevant context: Thiel has publicly identified with life-extension, neurotech, and trans-humanist investment theses. This is not evidence of a connection to iRestore, but it is a memetic co-location signal. **What is not supported:** - No evidence of a strategic relationship between Freedom Laser Therapy and Peter Thiel, Thiel Capital, or affiliated entities.[^18] - Broad direct-response advertising is a legitimate explanation for these placements. Hair-loss concern affects men across demographic cohorts, including those who follow anomalous-science content. - There is no documented statement from Craig Nabat or Freedom Laser Therapy positioning iRestore in consciousness, neurotechnology, or human enhancement discourse.[^8][^65] *** ### 3.7 Corporate-Genealogy Overlay **What is directly evidenced:** - Freedom Laser Therapy's founding purpose was modulation of neurochemical state: specifically, endorphin release, anxiety reduction, craving suppression, and reward pathway normalization through laser acupuncture.[^10][^66] - The company was publicly cited by Public Citizen for illegal off-label promotion of laser therapy for neurochemical modification (smoking cessation) — suggesting it pushed claims about neurological effects beyond what FDA would sanction.[^13] - The corporate through-line is: laser therapy as a tool for **behavioral and neurochemical change**, not merely tissue-level cosmetic outcome. The pivot to hair growth was a product-line expansion, not a paradigm shift.[^8][^9] - The Freedom Quit Smoking Laser wearable headset (separate product, ongoing) is explicitly designed to be worn on the head, targets ear acupuncture points, and is described as delivering "tranquil sensation throughout the user's mind and body".[^11] **What is inferential but plausible:** - The company's operational worldview has always been that low-level laser therapy can modify human behavioral state via neurochemical mechanisms. The transition to scalp application for hair growth may represent a regulatory-pathway-of-least-resistance strategy for deploying the same physical technology in a more easily cleared indication. - If iRestore's success funds further device development, the logical product-line extension — given both the corporate DNA and the adjacent patent ecosystem — would be toward neurovascular or neuromodulatory applications. **What is not supported:** - No public statement, internal document, or patent from Freedom Laser Therapy indicates a planned pivot to brain stimulation or neurotechnology.[^1][^8] - Corporate genealogy creates a plausible trajectory but is not predictive evidence. *** ### 3.8 Explicit-Language Overlay (Digital Twin / Continuity / Consciousness) **Freedom Laser Therapy / iRestore — direct materials:** - No language anywhere in iRestore's public materials, patents, FDA filings, app store descriptions, or corporate communications mentions: brain enhancement, digital twin, patient-specific modeling, cognition, neural oscillations, functional connectivity, digital phenotyping, consciousness, continuity, or substrate-independent identity.[^15][^14][^1] - This is an explicit absence and should be registered as such. **Adjacent ecosystem — direct language:** - **US11633621B2 (Vielight)**: explicitly mentions "brain-computer interface (BCI) feedback looping," "continuous and deep machine-learning AI," "modulating [the brain] to achieve targeted outcomes," "achieving higher level brain functions".[^53][^55] - **WO2022234544A1 (Sens AI)**: explicitly mentions "alter the electrical activity of the brain," "adapt patterned pulses of light in order to alter the electrical activity of the brain," EEG-based biometric adaptation.[^50] - **WO2022109365A1 (Raybalance)**: mentions "diagnosing or assessing a disease or disorder... monitoring responsiveness of the disease or disorder to treatment" — a proto-digital-twinning formulation.[^60] - No patent in the public record — by any author — explicitly mentions "digital twin," "continuity transfer," or "consciousness capture" in the context of PBM head devices.[^56][^58][^51][^50][^53] - The concept of "digital phenotyping" does appear in the peer-reviewed literature for wearable devices and behavioral monitoring, including in discussions of tPBM-adjacent therapeutic contexts.[^62][^67] *** ## 4. Sponsorship Habitat Audit | Show / Channel | Evidence of iRestore Sponsorship | Sponsor Language | Thematic Content | Why Ordinary or Non-Ordinary | |---|---|---|---|---| | **American Alchemy with Jesse Michels** | Active multi-episode sponsorship with exclusive discount codes; confirmed in YouTube description, Spotify description, Apple Podcasts description, X.com post[^16][^17][^63] | "iRestore: Unlock your best hair & skin with @iRestorelaser and HUGE savings on the iRestore Elite" | UFO witnesses, simulation theory, consciousness transmission, ancient alien archaeology, Area 51 whistleblowers, AGI, qualia, government UAP disclosure, heretical science[^20][^21][^23] | **Non-ordinary for hair-loss brand.** No semantic adjacency to androgenetic alopecia. Audience is organized around post-materialist cosmology and anomalous technology. Consistent with either broad reach-buying or intentional memetic positioning in human-optimization discourse | | **Impact Theory with Tom Bilyeu** | Confirmed sponsorship via partnerships page and advertising listing[^24][^25] | Hair growth / self-improvement branding | AI revolution, simulation theory, neural interfaces, life after death, radical self-optimization, entrepreneur mindset, AGI[^26][^27][^64] | **Partially ordinary.** Impact Theory's "human potential / self-optimization" frame has broader commercial compatibility with hair-loss anxiety as self-improvement purchase. However, content regularly extends into consciousness, AI, and post-biological futures | No additional iRestore sponsorship placements were confirmed in primary sources beyond these two shows during the research period. *** ## 5. Patent and Statement Audit ### Freedom Laser Therapy / iRestore — Direct Materials No patents or public statements found mentioning: brain enhancement, brain-related conditions, closed-loop PBM, adaptive dosing, digital twin, patient-specific modeling, cognition, neural oscillations, network effects, continuity, or consciousness. **Confirmed Freedom Laser Therapy intellectual property activity:** - 510(k) submissions K222081 (Elite), K213094 (ID-500), K183417 (Pro 282) — all limited to hair growth indication[^1][^68] - Freedom Quit Smoking Laser device (wearable; patent-pending as of 2020) — ear acupuncture LLLT, addiction/withdrawal[^49][^11] - No additional USPTO patent assignments to Freedom Laser Therapy, Inc. or Craig Nabat for brain, neural, or cognitive applications were found in public searches ### Adjacent Ecosystem — Brain/Neural/Adaptive/Cognitive PBM Patents | Patent | Assignee | Key Claims | Relevance | |---|---|---|---| | US11633621B2 | Vielight Inc.[^53][^55] | AI+BCI-driven personalized brain PBM; EEG targets; ML-adaptive; psychiatric/cognitive improvement | Highest: exact AI-brain-PBM-digital-modeling convergence | | WO2022234544A1 | Sens AI Inc.[^50] | Closed-loop adaptive tPBM using EEG biometric signals to alter brain electrical activity | Highest: closed-loop neural modulation via head-worn PBM | | WO2023161861A1 | Sens AI Inc.[^51][^52] | Head-wearable EEG+tPBM with cognitive testing for user cognitive status evaluation | High: PBM + cognitive phenotyping in wearable form | | WO2022109365A1 | Raybalance Inc.[^60] | PBM system with disease diagnosis, treatment monitoring, and data analytics integration | High: proto-digital-twin monitoring architecture | | US11986667B2 | Jelikalite LLC[^58][^59] | Head-wearable device for neurological conditions using red+NIR, mobile device data analysis | Medium-high: explicitly neurological, head-worn, mobile-connected | | US10987521B1 | HOPE Laser Institute[^56][^57] | Brain condition treatment (concussion, neurological) via PBM protocol | Medium: clinical brain PBM system | | US11730917B2 | Optoceutics/DTU[^61] | Gamma (40Hz) pulsing light for Alzheimer's/sleep with adaptive dosage | Medium: specific brain target, consumer-facing pathway | **No patent in any public database** — by Freedom Laser Therapy or any other entity — explicitly uses the terms "digital twin," "consciousness," "continuity transfer," or "substrate-independent identity" in the context of PBM head devices. *** ## 6. MAUDE / TPLC Forensic Reading ### Aggregate TPLC Data (Product Code OAP, All Manufacturers, 2021–2025) Total MDRs: 8 across 4 reporting years. This is a small n and should not be over-interpreted.[^6] **Patient problem breakdown (with commentary):** | Patient Problem | MDRs | Forensic Interpretation | |---|---|---| | Hair Loss | 3 | Paradoxical effect — device intended to reverse hair loss; consistent with telogen effluvium triggered by photonic stimulus or placebo/natural course; not neurological | | Headache | 3 | **Ambiguous.** Can result from scalp muscle tension (helmet pressure), thermal effects, photosensitivity, or off-target cranial/neurovascular photonic exposure. Overlaps with documented tPBM adverse-event profile[^32] | | No Clinical Signs | 2 | Manufacturer-resolved without documented harm | | Hypersensitivity/Allergic reaction | 1 | Local skin reaction; non-neurological | | Cyst(s) | 1 | Consistent with scalp tissue reaction to photonic/thermal stimulus | | Itching Sensation | 1 | Local dermal response | | Burns | 1 | Thermal adverse event; possible overexposure | | Erythema | 1 | Local vascular dilation; consistent with photonic scalp effects | | Pain | 1 | Nonspecific; could be scalp or referred | | Hemorrhage/Bleeding | 1 | Associated with cyst formation in narrative text[^7] | **From MAUDE narrative text (MDR ID 12066670):** The patient specifically references user community reports of: "severe headaches, itchy scalp, unbearable pain, eye irritation, **sleeplessness due to headaches**, rash, scalp damage, scalp pain, **inner ear pain**".[^7] **Forensic interpretation:** - "Sleeplessness due to headaches" suggests a persistent or recurring headache pattern severe enough to disrupt sleep — a symptom profile more suggestive of cephalic neurological or vascular involvement than simple scalp reaction. - "Inner ear pain" is especially notable: the inner ear is not located on the scalp surface and is not targetted by the device. Inner ear pain in the context of a head-worn light device raises questions about transmitted vibration, pressure, acoustic effects of the device's electronics, or (more speculatively) photonic or thermal effects on temporal bone and inner ear structures through adjacent tissue. - "Eye irritation" is consistent with light scatter reaching the retina; iRestore's device labeling instructs users to keep eyes closed or use protective eyewear. **What MAUDE can and cannot prove:** - MAUDE reports are voluntary, unsystematic, and have no denominator (reported device units or user-sessions). They cannot establish causation. - They demonstrate that a subset of users experienced symptoms — including headache, sleeplessness, and inner ear pain — that they attributed to device use. - The symptom overlap with documented tPBM adverse-event profiles (headache, unusual sensations, vivid colors/irritation, dizziness) is consistent with, but does not prove, off-target cranial photonic effects.[^32][^40] - Alternative explanations for headaches include: helmet pressure, muscle tension, thermal effects on scalp vasculature, placebo expectation reversal, and coincidental tension headaches.[^6] *** ## 7. Strongest Defensible Future Pathway The following pathway is built from what is technically demonstrated in the literature and patent record, not from speculation. Each step is labeled by evidentiary status. ### Step 1: Normalized consumer cranial light habituation [**Already true**] iRestore has created a population of daily users habituated to wearing a light-emitting helmet for 12 minutes per day, indefinitely. The physical habit, the helmet form factor, and the basic behavioral compliance loop (app-mediated reminders, session logs) are established.[^2][^14] ### Step 2: Upgrade to NIR wavelengths within same regulatory pathway [**Adjacent and plausible**] Adding 810nm or 1,064nm NIR emitters to the same helmet form factor requires hardware modification but no fundamental regulatory reclassification, provided the device retains its cleared hair-growth indication (NIR has equal or greater evidence for hair follicle stimulation) and predicate devices using NIR exist (they do: Vielight products). This upgrade would cross the threshold from cosmetic scalp stimulation into the demonstrated therapeutic range for transcranial PBM.[^69][^48] ### Step 3: Integration of passive EEG sensors into helmet shell [**Adjacent and plausible; being built by others**] Dry-electrode EEG sensing integrated into helmet-form-factor head-worn devices is technically mature (consumer EEG headsets from Emotiv, Muse, etc., are already commercially available). Combined tPBM+EEG wearables are described in multiple pending patents (Sens AI's WO2022234544 and WO2023161861). Adding passive EEG to an existing cranial light helmet requires modest engineering but no new scientific breakthroughs.[^51][^50][^52] ### Step 4: App-mediated digital phenotyping of user behavioral-cognitive state [**Adjacent and plausible; partially present**] The existing iRestore app already captures longitudinal session compliance, before/after photos (scalp appearance time-series), user notes, and usage patterns. Adding cognitive assessments (reaction time tasks, mood ratings, subjective cognitive state logs) to the same app interface requires only software development. This would constitute proto-digital phenotyping of the user's cognitive-behavioral state, creating a longitudinal dataset associated with cranial light exposure.[^14][^62][^67] ### Step 5: Closed-loop adaptive photonic dosing [**Forward-looking but coherent; being built by adjacent actors**] With EEG data and cognitive state logs feeding back into the app, pulsed light delivery parameters (frequency, duty cycle, power level) could be adapted in response to real-time or recent neural state measurements — the exact architecture described in Sens AI's closed-loop tPBM patents. This step converts the device from a fixed-protocol lamp into a responsive neural modulation system.[^51][^50] ### Step 6: AI-personalized brain modulation model [**Forward-looking but coherent; patent exists**] With sufficient longitudinal data (session logs, EEG states, cognitive performance, photographic scalp biomarkers), ML models could generate individualized treatment profiles — the architecture described and patented by Vielight (US11633621B2). This step crosses from treatment delivery into patient-specific neural modeling.[^53][^55] ### Step 7: Behavioral and cognitive state inference from longitudinal wearable data [**Forward-looking but coherent; literature supports concept**] Digital phenotyping research demonstrates that longitudinal compliance and behavioral data from wearable devices can support inference of cognitive and psychiatric state. A user's session adherence patterns, note content, photo-assessed scalp/health appearance trajectories, and app interaction patterns constitute a behavioral phenotype that could theoretically be used for cognitive state inference — not through explicit measurement but through behavioral correlate modeling.[^62][^67] ### What this pathway does NOT include (and why): - **Continuity transfer**: No step in this pathway involves identity capture, consciousness upload, or substrate-independent identity preservation. These categories require completely different technology (neural connectomics, whole-brain emulation) that is not on this engineering roadmap. - **Digital twinning in the full sense**: Creating a computational model of a specific individual's neural state requires far higher-resolution data than any surface photonic device can provide. - **Consciousness reading**: Inferring subjective experience from photonics+EEG is far beyond current science. The pathway above describes a plausible trajectory from consumer hair-growth device to **consumer adaptive cranial neuromodulation platform** — a meaningful category but far short of the more dramatic formulations sometimes associated with these discussions. *** ## 8. Strongest Objections ### 8.1 The Sponsorship Is Ordinary Direct-Response Media Buying Androgenetic alopecia affects approximately 50–80% of men by age 70 and 40% of women by age 40. The demographic overlap between hair-loss sufferers and the podcast audiences of American Alchemy (men aged 25–45 interested in heretical ideas) and Impact Theory (self-optimizing professionals aged 25–50) is genuine and substantial. Both shows have large audiences with the disposable income to purchase a $1,899 device. A media buyer selecting shows by CPM and audience demographics, with no symbolic agenda, might land on exactly these shows. The "non-ordinary" interpretation of the sponsorship requires ruling out the simpler explanation, which cannot be done from public evidence alone.[^20][^24] ### 8.2 The iRestore MAUDE Signal Is Tiny and Explainable Without Brain Hypothesis Eight total MDRs across all OAP manufacturers over four years is a very low event count relative to installed device base. Headaches from helmet pressure, scalp vasodilation from heat, and coincidental tension headaches are individually sufficient to explain the headache signal. "Sleeplessness due to headaches" would follow from any persistent headache, not necessarily a neurological one. "Inner ear pain" might reflect pressure of the device's hardware on periauricular structures rather than transmitted photonic effects.[^7][^6] ### 8.3 The Wavelength Gap Is Real and Large The tPBM literature demonstrating brain effects is overwhelmingly based on 810nm and 1064nm wavelengths. The penetration depth advantage of these wavelengths over visible red (625–680nm) is not incremental — it is structural. At 660nm, the vast majority of light is absorbed and scattered in the dermal and subdermal layers well above the skull. The fraction reaching cortical tissue is likely below any threshold that could produce measurable neurochemical effects during a 12-minute session. Porting the 810nm brain-effect literature to iRestore's visible-red device is a significant scientific leap that is not warranted by the available data.[^47][^39][^29] ### 8.4 Corporate Genealogy Proves Only Enthusiasm for LLLT, Not Hidden Neurotechnology Agenda Craig Nabat is most parsimoniously understood as an LLLT enthusiast who used laser therapy personally, built a clinical business on it, and has spent decades evangelizing LLLT for whatever biological application has market potential (smoking cessation, hair growth). The neurochemical framing of the smoking cessation product is accurate LLLT science (endorphin release via auricular stimulation is documented) but doesn't imply a hidden agenda for iRestore — it simply reflects a consistent belief in LLLT's broad bioactive potential.[^8][^10][^65] ### 8.5 The App Telemetry Is Standard Consumer Data Practice The data collected by the iRestore app (contact info, user content, identifiers, usage data) matches what any consumer wellness app routinely collects for account management, customer service, and targeted advertising purposes. There is no evidence this data is being sold, analyzed for biological inference, or integrated into any research pipeline. Calling it a "digital phenotyping scaffold" applies a technical label that exceeds what the evidence supports for current practice.[^15][^14] ### 8.6 Freedom Laser Has No Brain Patents and No Stated Brain Intent The total absence of any brain-directed IP from Freedom Laser Therapy is not easily explained away. If the company had strategic brain-technology ambitions, 23 years of operation would have produced at least one patent, research collaboration, or public statement reflecting this. The absence of such evidence is itself evidence against the ambitious interpretation.[^8][^1][^68] *** ## 9. Bottom Line **iRestore is best understood as: a biologically interesting cranial PBM product with unexplored off-target implications, operating as an unintentional ancestral node in an emerging cranial-neurotechnology stack.** This is the fourth option listed in the query, and it emerges as the most defensible synthesis of the evidence. Breaking this down: - **It is not "just a hair-growth lamp"** because: (a) it delivers 2,500 mW of photons to the full upper cranial surface, incident on cortex-overlying skull, in a form factor physically identical to brain-PBM helmets; (b) its corporate genealogy is explicitly rooted in neurochemical modulation; (c) its advertising habitat is irreducibly anomalous for a cosmetic device; (d) its adverse-event profile is partially consistent with off-target cranial photonic effects; and (e) the scientific question of what visible-red photons at iRestore power levels do to superficial cortex has never been formally evaluated.[^2][^10][^1][^6][^32] - **It is not a covert neurotechnology platform** because: no patent, filing, statement, or technical specification from Freedom Laser Therapy indicates brain-directed design intent, and the wavelength gap between iRestore's visible-red outputs and established tPBM brain-effect wavelengths is real and scientifically significant.[^47][^1] - **It is an unintentional ancestral node** because: the consumer cranial light habituation pattern it normalizes, the app compliance architecture it establishes, and the physical form factor it popularizes are all structurally pre-adapted for integration into the closed-loop adaptive cranial neurotechnology stack that is being actively built by adjacent actors. A company — or an acquirer — with the adjacent IP and scientific intent could in principle upgrade iRestore's successor products with NIR emitters, EEG sensors, and AI-adaptive dosing software, inheriting a large established user base already habituated to daily cranial photonic exposure and already enrolled in a longitudinal data-collection platform.[^50][^53][^60] - The **discursive habitat** in which iRestore advertises is either the most expensive coincidence in direct-response media buying history, or a low-amplitude but meaningful signal that the brand understands itself — consciously or not — as belonging to the technology-enhanced human biology discourse rather than the cosmetic-defect-correction discourse. This signal is real but cannot be quantified.[^16][^17][^23] **The strongest steelman of the ambitious reading** is: A company founded on the principle that light can modify human neurochemical state, operating a consumer cranial photonic device with daily-use habituation patterns, app-mediated longitudinal telemetry, and advertisements placed exclusively in consciousness-edge media — in a moment when the adjacent patent ecosystem is actively building every component needed to turn such a device into a closed-loop neural modulator — represents an architectural precursor to consumer neurotechnology whether or not its current operators intend it as such. The infrastructure of normalization (daily head-worn light exposure), data collection (session logs, biometric photos), and behavioral shaping (compliance app) is already in place. The technology upgrade from hair-growth device to adaptive cranial modulator is short, technically coherent, and documented in adjacent IP. **The strongest steelman of the skeptical reading** is: The evidence for any brain-directed function or intent is entirely inferential, built from circumstantial pattern-matching between an ordinary consumer device and a technology trajectory it doesn't actually occupy. The wavelength gap is real, the patents are held by others, the adverse-event n is minuscule, and the sponsorship choices may simply reflect good direct-response demographics. Freedom Laser Therapy is a small California company selling a hair-growth helmet. The elaborate interpretive architecture surrounding it may reveal more about the interpreter's pattern-recognition tendencies than about the device itself. Both steelmans survive contact with the evidence. The evidence does not adjudicate between them. What it establishes is that **the question is non-trivial** — which is itself the most forensically defensible conclusion. *** ## 10. Signal Overlay Ranking Table | Signal Layer | Signal Strength | Evidentiary Quality | Relevance to Ambitious Interpretation | Main Limitation | |---|---|---|---|---| | **Device / Hardware** | Medium-High | High (primary FDA docs) | High — full-scalp cranial photon delivery at optical-window wavelengths | Wavelength gap to established brain-PBM spectrum is large; no brain dosimetry data[^1][^47] | | **Regulatory Anomaly** (visible red cleared as "infrared lamp") | Medium | High (direct CFR text) | Medium — indicates classification drift but is a routine 510(k) artefact[^5][^1] | Predicate cascade is standard regulatory practice, not evidence of intent | | **MAUDE / Adverse Events** | Low-Medium | Low-Medium (small n, unverified causation) | Medium — headache + sleeplessness + inner ear pattern overlaps tPBM adverse-event profile[^6][^7][^32] | Tiny database; every symptom has mundane alternative explanation | | **tPBM Science** | Low-Medium (for iRestore wavelengths) | High (peer-reviewed literature) | Medium — biological plausibility exists but is far below demonstrated threshold[^29][^30][^48] | Strong evidence is at 810–1064nm, not 625–680nm | | **Corporate Genealogy** | High | High (primary corporate records, public statements) | High — company explicitly founded on neurochemical laser modulation; named in FDA enforcement action for off-label neuro claims[^8][^10][^13] | Does not prove brain intent for hair-growth product specifically | | **Adjacent Patent Ecosystem** | Very High | Very High (primary patent records) | Very High — every functional component of closed-loop brain PBM + AI-personalized neural modulation already exists in adjacent IP[^50][^53][^60] | None of these patents are held by Freedom Laser Therapy | | **Telemetry / App Architecture** | Low-Medium | Medium (App Store privacy labels) | Low-Medium — standard consumer data grammar; minimal evidence of analytical use[^14][^15] | Current telemetry is typical of any wellness app | | **Discursive Habitat / Sponsorship** | Medium | Medium (primary episode listings) | Medium-High — sponsorship in consciousness-edge media is contextually anomalous for cosmetic device[^16][^17][^23] | Cannot rule out ordinary demographic reach-buying | | **Freedom Laser Direct Language** | None | High (exhaustive search of public record) | Negative signal — no brain, neural, or continuity language anywhere in company materials | Absence of language is strong evidence against active neurotechnology agenda | | **Digital Twinning / Continuity Specific** | None in any PBM context | High | N/A — these categories are not present in any PBM head-device patent or filing | Entire category is speculative projection; not in the public record | --- ## References 1. [[PDF] October 13, 2022 Freedom Laser Therapy, Inc. Sharon Chen ...](https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222081.pdf) - The ID-510 iRestore Elite is indicated to promote hair growth in males who have Norwood-. Hamilton C... 2. [iRESTORE Elite | FDA-Cleared Hair Growth Laser Device](https://www.irestorelaser.com/products/laser-hair-growth-system-elite) - Total Power Output: 2500mW · Light Source: 500 Diodes (300 Lasers & 200 LEDs) · Laser Power Classifi... 3. [iRESTORE Professional | FDA-Cleared Hair Growth Device](https://www.irestorelaser.com/products/laser-hair-growth-system-professional) - Total Power Output: 1410mW · Light Source: 282 Diodes (82 Lasers & 200 LEDs) · Laser Power Classific... 4. [iRESTORE Essential | FDA-Cleared Red Light Hair Growth Device](https://www.irestorelaser.com/products/laser-hair-growth-system-essential) - Total Power Output: 600mW · Laser Power Classification: Class 3R (<5mW) · Wavelength: 655nm (Red Lig... 5. [21 CFR § 890.5500 - Infrared lamp. - Law.Cornell.Edu](https://www.law.cornell.edu/cfr/text/21/890.5500) - § 890.5500 Infrared lamp. (a) Identification. An infrared lamp is a device intended for medical purp... 6. [TPLC - Total Product Life Cycle - FDA](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfTPLC/tplc.cfm?id=OAP) - Events in those MDRs. No Clinical Signs, Symptoms or Conditions63, 10, 10. Headache64, 6, 6. Hair Lo... 7. [MAUDE Adverse Event Report: FREEDOM LASER THERAPY, INC ...](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=12066670&pc=OAP) - Taken from the irestore website, goes on to state that ¿there are no negative side effects when usin... 8. [Craig Nabat | LinkedIn](https://www.linkedin.com/in/craignabat) - President 9. [Freedom Laser Therapy Company Overview, Contact ... - LeadIQ](https://leadiq.com/c/freedom-laser-therapy/5a1da8e023000052009ce7bf) - Learn more about Freedom Laser Therapy's company details, contact information, competitors, and more... 10. [The Best Way to Quit Smoking or Quit Vaping in Los Angeles ...](https://www.freedomquitsmoking.com) - Quit smoking & quit vaping with Freedom Laser's non-invasive low-level laser therapy procedure in Lo... 11. [Crowdfunding Campaign: Freedom Quit Smoking Relaxation Light Therapy Headset](https://merxwire.com/6771/crowdfunding-campaign%EF%BC%9Afreedom-quit-smoking-relaxation-light-therapy-headset/) - FREEDOM LASER, LLC. Launched a new patented: Freedom Quit Smoking Relaxation Light Therapy Headset, ... 12. [Device Benefits - Freedom Quit Smoking Laser](https://freedomquit.com/device-benefits-1) - The Freedom Quit Smoking Laser was invented to be a drug-free and non-invasive method for smokers to... 13. [Letter Asking FDA to Stop Companies from Promoting Laser ...](https://www.citizen.org/article/letter-asking-fda-to-stop-companies-from-promoting-laser-therapy-for-smoking-cessation/) - The clinics, Freedom Laser Therapy Inc., the Anne Penman Laser Therapy clinics, New Beginnings Laser... 14. [iRESTORE - App Store](https://apps.apple.com/us/app/irestore/id6740624438) - The following data may be collected but it is not linked to your identity: Diagnostics. Privacy prac... 15. [Privacy Policy - iRESTORE](https://irestorehelmet.com/privacy-policy/) - You can also withdraw consent for product usage data collection by adjusting settings in the iRESTOR... 16. [“We Captured a 12 Foot Giant in Afghanistan!” -Tim Alberino](https://www.youtube.com/watch?v=CiQTBOQ1dTg) - Sign Up With Our Sponsors Below For Exclusive Alchemy Deals! iRestore: Unlock your best hair & skin ... 17. [American Alchemy with Jesse Michels - Apple Podcasts](https://podcasts.apple.com/us/podcast/american-alchemy-with-jesse-michels/id1771917740) - Sign Up With Our Sponsors Below For Exclusive Alchemy Deals! iRestore: Unlock your best hair & skin ... 18. [American Alchemy | Jesse Michels | Episode 145 - Infinite Loops](https://www.infiniteloopspodcast.com/videos/american-alchemy-jesse-michels-episode-145/) - Jesse Michels is an investor at Thiel Capital and the creator and host of ‘American Alchemy’, a Yout... 19. [American Alchemy with Jesse Michels - Apple Podcasts](https://podcasts.apple.com/mo/podcast/american-alchemy-with-jesse-michels/id1771917740) - Welcome to the American Alchemy hosted by Jesse Michels. Tune in for new videos WEEKLY highlighting ... 20. [“We Captured a 12 Foot Giant in Afghanistan!” -Tim Alberino - Spotify](https://open.spotify.com/episode/7Dq6AUD9Z1dcJw04wJhyRU) - Listen to this episode from American Alchemy with Jesse Michels on Spotify. Our American ... Sponsor... 21. [American Alchemy with Jesse Michels – Podcast - Podtail](https://podtail.com/podcast/jesse-michels/) - “I Spent 3 Years With Tall White Aliens At Area 51" -UFO Whistleblower Charles Hall. 11 Sep 2025 ... 22. [In this episode of American Alchemy, Jesse Michels sits down with ...](https://www.reddit.com/r/HighStrangeness/comments/1hk7daq/in_this_episode_of_american_alchemy_jesse_michels/) - ... UFO. 80. 46. American Alchemy with Jesse Michels | Eric Weinstein Confronts Government Scientist... 23. [American Alchemy | Jesse Michels | Episode 145](https://www.youtube.com/watch?v=Rm0Z7aFV4aE) - Jesse Michels is an investor at Thiel Capital and the creator and host of ‘American Alchemy’, a Yout... 24. [Impact Theory Partnerships](https://impacttheory.com/partnerships) - The Impact Theory Network is a curated collection of top creators built to deliver high-performance ... 25. [Advertise on Impact Theory with Tom Bilyeu - Gumball.fm](https://gumball.fm/shows/impact-theory-with-tom-bilyeu) - Impact Theory is a business and mindset-focused interview show that will teach anyone aspiring to gr... 26. [New Physics Reveals the Truth Behind Simulation Theory & Life ...](https://www.audible.com/podcast/New-Physics-Reveals-the-Truth-Behind-Simulation-Theory-Life-After-Death-Rizwan-Virk-PT-2/B0FDKGTG2G) - Picking up where we left off, Part 2 of this fascinating episode with Rizwan Virk and Tom Bilyeu div... 27. [You Have 2 Years Left Before Everything Gets Rewritten | Tom Bilyeu Deep Dive – Tom Bilyeu's Impact Theory](https://pod.pe/podcast/impact-theory-with-tom-bilyeu/you-have-2-years-left-before-everything-gets-rewri) - Welcome to Impact Theory with Tom Bilyeu! 28. [Tom Bilyeu's Impact Theory - Podcast Episode | Global Player](https://www.globalplayer.com/podcasts/episodes/7Drofpq/) - AI Uprising, Fluoride Debate, and Trump’s Shocking Economic Plan | The Tom Bilyeu Show 29. [Brain Photobiomodulation Therapy: A Narrative Review - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6041198/) - [91] reported penetration depths of 0.79 mm (630 nm), 0.83 mm (670 nm), 0.9 mm (850 nm), and 1 mm (1... 30. [A new perspective on delivery of red-near-infrared light therapy for ...](https://pubmed.ncbi.nlm.nih.gov/27755969/) - Transmission through brain tissue ranged from 1-7%, following an approximately linear relationship b... 31. [Neuro Gamma 4: Transcranial Photobiomodulation Helmet - Vielight](https://www.vielight.com/devices/vielight-neuro-gamma/) - Engineered as a next-generation near infrared helmet, this modular system uses 5 high-power Vie-LEDs... 32. [Team Assesses Safety of t-PBM, Non-Invasive Brain Stimulation ...](https://bbrfoundation.org/content/team-assesses-safety-t-pbm-non-invasive-brain-stimulation-technology-uses-light-treat) - The last decade has seen a vast increase in the use of brain stimulation technologies to reduce symp... 33. [How It Works – iRESTORE](https://www.irestorelaser.com/pages/how-it-works) - iRESTORE is the only system to combine lasers & LEDs to provide complete scalp coverage and ensure l... 34. [Effects of transcranial photobiomodulation in cerebral circulation and brain neural oscillations: a systematic review - PubMed](https://pubmed.ncbi.nlm.nih.gov/40844561/) - Transcranial photobiomodulation (tPBM) uses the light of lasers or light-emitting diodes to modulate... 35. [A systematic review of the effects of transcranial photobiomodulation on brain activity in humans - PubMed](https://pubmed.ncbi.nlm.nih.gov/36927734/) - In recent years, transcranial photobiomodulation (tPBM) has been developing as a promising method to... 36. [Transcranial 1064-nm laser photobiomodulation modulates ... - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC12823878/) - Transcranial photobiomodulation (tPBM) with near-infrared light is a promising non-invasive method t... 37. [Transcranial 1064-nm Laser Photobiomodulation ...](https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2025.1704482/full) - Introduction Transcranial photobiomodulation (tPBM) with near-infrared light is a promising non-inva... 38. [Quantitative analysis of transcranial and intraparenchymal light ...](https://lightforcemedical.com/quantitative-analysis-of-transcranial-and-intraparenchymal-light-penetration-in-human-cadaver-brain-tissue/) - This study investigated the light penetration gradients in the human cadaver brain using a Transcran... 39. [[PDF] A realistic Monte Carlo simulation study - Researching](https://www.researching.cn/ArticlePdf/m00092/2017/10/5/1743002.pdf) - P. J. Muller, B. C. Wilson, \An update on the penetration depth of 630nm light in normal and maligna... 40. [Reported Side Effects, Weight and Blood Pressure, After Repeated Sessions of Transcranial Photobiomodulation | Photobiomodulation, Photomedicine, and Laser Surgery](https://www.liebertpub.com/doi/abs/10.1089/photob.2019.4678) - Abstract Background: Transcranial photobiomodulation (t-PBM) consists in the delivery of near-infrar... 41. [Reported Side Effects, Weight and Blood Pressure, After ...](https://pubmed.ncbi.nlm.nih.gov/31647774/) - <span><b><i>Background:</i></b> Transcranial photobiomodulation (t-PBM) consists in the delivery of ... 42. [A randomized placebo-controlled study of a transcranial photobiomodulation helmet in parkinson’s disease: Post-Hoc analysis of motor outcomes](https://researchoutput.csu.edu.au/en/publications/a-randomized-placebo-controlled-study-of-a-transcranial-photobiom) 43. [Brain Biohacking with Photobiomodulation (Red Light)](https://www.andrewhillphd.com/articles/brain-biohacking-photobiomodulation) - Penetration: 30-40mm; Reaches cortical surface through skull; Most extensively studied wavelength fo... 44. [Light Penetration: Photobiomodulation with Red and Near-Infrared ...](https://occupationaltherapybrisbane.com.au/red-light-brain-penetration/) - Yes. Clinical studies show red light therapy can reach the brain to a depth of several millimetres—e... 45. [Photobiomodulation Therapy on Brain: Pioneering an Innovative ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC11171912/) - Photobiomodulation (PBM) therapy on the brain employs red to near-infrared (NIR) light to treat vari... 46. [Photobiomodulation Therapy on Brain: Pioneering an Innovative ...](https://pubmed.ncbi.nlm.nih.gov/38891098/) - Photobiomodulation (PBM) therapy on the brain employs red to near-infrared (NIR) light to treat vari... 47. [[PDF] Photon penetration depth in human brain for light stimulation ...](https://www.semanticscholar.org/paper/Photon-penetration-depth-in-human-brain-for-light-A-Li-Xue/be84c3368a6bdc9cb10ee57d79ee7a4609325137) - Photon penetration depth in human brain for light stimulation and treatment: A realistic Monte Carlo... 48. [Red Light Therapy for Brain & Nervous System: Clinical Evidence ...](https://mitoredlight.com/pages/red-light-therapy-for-brain-nervous-system-clinical-evidence) - 1064 nm appears superior to 810 nm for skull penetration based on Monte Carlo light transport modeli... 49. [Freedom Laser - Netcapital](https://netcapital.com/companies/freedomlaser) - Invest in the future of health: disrupt the $2 billion U.S. smoking cessation industry with our pate... 50. [Method for interval closed-loop adaptive transcranial photobiomodulation](https://patents.google.com/patent/WO2022234544A1/en) - Methods for brainwave modulation using interval based closed-loop adaptive transcranial photobiomodu... 51. [WO2023161861A1 - Method and apparatus for wearable device for ...](https://patents.google.com/patent/WO2023161861A1/en) - Devices and methods for stimulation and modulation of brain activity using transcranial photobiomodu... 52. [U.S. Patent Application for Method and Apparatus for Wearable ...](https://patents.justia.com/patent/20250152967) - Devices and methods for stimulation and modulation of brain activity using transcranial photobiomodu... 53. [Vielight Founder, Dr. Lew Lim Granted a Patent for - GlobeNewswire](https://www.globenewswire.com/news-release/2023/07/13/2704697/0/en/Vielight-Founder-Dr-Lew-Lim-Granted-a-Patent-for-Artificial-Intelligence-AI-Brain-Stimulation-Assigns-to-Vielight-Inc.html) - The patent involves the use of artificial intelligence (AI) to automate intervention with photobiomo... 54. [Vielight Founder, Dr. Lew Lim Granted a Patent for Artificial Intelligence (AI) Brain Stimulation & Assigns to Vielight](https://aithority.com/machine-learning/vielight-founder-dr-lew-lim-granted-a-patent-for-artificial-intelligence-ai-brain-stimulation-assigns-to-vielight/) - Vielight, pleased to announce that Dr Lim, who is its Founder & CEO, assigned this intellectual prop... 55. [System and method for automated personalized brain modulation with photobiomodulation](https://patents.justia.com/patent/11633621) - A novel photobiomodulation (PBM) system and method that comprehensively directs therapeutic light en... 56. [System and methods for treating brain related conditions with ...](https://patents.google.com/patent/US10987521B1/en) - Photobiomodulation or low level light therapy is applied to the brain using a treatment protocol tha... 57. [System and methods for treating brain related conditions with photobiomodulation therapy - Eureka | Patsnap](https://eureka.patsnap.com/patent-US10987521B1) - Photobiomodulation or low level light therapy is applied to the brain using a treatment protocol tha... 58. [Methods and devices for photobiomodulation](https://patents.google.com/patent/US20210205634A1/en) - Systems and methods are described for treatment of neurological conditions in which transcranial ill... 59. [methods and devices for photobiomodulation](https://patents.justia.com/patent/20250288823) - Systems and methods are described for treatment of neurological conditions in which transcranial ill... 60. [Systems and methods for photobiomodulation](https://patents.google.com/patent/WO2022109365A1/en) - The present application is directed to systems, devices, and methods for diagnosing, preventing, and... 61. [US11730917B2 - Gamma stimulation pulsing light source system ...](https://patents.google.com/patent/US11730917B2/en) - Gamma brain stimulation for preventing or treating Alzheimer's disease or sleeping disorders using l... 62. [Digital phenotyping approaches and mobile devices enhance CNS ...](https://pmc.ncbi.nlm.nih.gov/articles/PMC6224520/) - Digital phenotyping is one result of the interaction between pervasive personal technology, patients... 63. [Jesse Michels (@AlchemyAmerican) on X](https://x.com/AlchemyAmerican/status/2040873276264661502) - Sign Up With Our Sponsors Below For Exclusive Alchemy Deals!iRestore: Unlock your best hair & skin w... 64. [Impact Theory with Tom Bilyeu](https://podcasts.google.com/feed/aHR0cHM6Ly9pbXBhY3R0aGVvcnkubGlic3luLmNvbS9yc3M) - If you’re looking to thrive in uncertain times, achieve unprecedented goals, and improve the most me... 65. [Freedom Laser Therapy Introduces the Two Innovations that Will ...](https://www.prweb.com/releases/freedom_laser_therapy_introduces_the_two_innovations_that_will_change_health_and_beauty_in_2016/prweb13187779.htm) - His latest innovation – the iRestore Hair Growth System – is a FDA-cleared device to treat hair loss... 66. [Quit Smoking & Vaping with LLLT - Freedom Laser Therapy](https://www.freedomquitsmoking.com/blog/low-level-laser-therapy-device-can-help-you-quit) - By stimulating these acupuncture points with cold low-level lasers, the therapy helps trigger the re... 67. [Study Details | NCT07222449 | ClinicalTrials.gov - ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT07222449) - Wearable, self-administered transcranial photobiomodulation for major depressive disorder and sleep:... 68. [[PDF] Freedom Laser Therapy, Inc. Mr. Raymond Blanche Consultant NST ...](https://www.accessdata.fda.gov/cdrh_docs/pdf18/K183417.pdf) - The iRestore Professional 282 is indicated to promote hair growth in females with androgenetic alope... 69. [Shining light on the head: Photobiomodulation for brain disorders](https://pmc.ncbi.nlm.nih.gov/articles/PMC5066074/) - estimated that the mean penetration depth (5% remaining intensity) of NIR light through the scalp an...